Investigators reviewed DNA methylation patterns and how they can aid in differential diagnoses for patients with lacrimal ...

An AI-powered platform can advance the processing speed of data from large multi-center clinical trials.

Investigators reviewed ocular side effects of semaglutide use from a global population-based study across 180 countries.

Researchers compared the use of aflibercept 8 mg and 2 mg in patients with various retinal vein occlusion subtypes.

In 2 phase 3 studies, acoltremon 0.003% met primary endpoints, demonstrating statistically significant tear production at day 14.

Researchers assessed the quality of life measures of patients with thyroid eye disease treated with Veligrotug, a full antagonist humanized mAb to IGF-1R.

Investigators reviewed the long-term outcomes of patients who completed the PANORAMA clinical trial and have since sought standard clinical care.

Explainable artificial intelligence (XAI) can identify clinically significant diabetic retinal neurodegeneration (DRN) on ...

A phase 2 study supports the use of a microRNA eye drop for patients with corneal damage or dry eye disease.

The study published in JAMA Ophthalmology – the first epidemiologic study to home in on eye injuries in pickleball – reviewed ...

The FDA has approved Epioxa™ HD 0.239% and Epioxa™ 0.177% for use in epithelium-on corneal collagen CXL for the treatment of ...